3. Additional reviews relevant to aggression and suggested from excluded studies.
Aripiprazole | Combination | Comparison #1 | Comparison #2 | Excluded study | Suggested title of review | Cochrane review | |
IM | Short acting | + quetiapine | aripiprazole + olanzapine | quetiapine + olanzapine | Wang 2014 | Antipsychotic combinations for psychosis‐induced aggression or agitation (rapid tranquillisation) | None |
Long acting (441mg) | Long acting (882 mg) | placebo | NCT0146903* | Aripiprazole for long‐term aggression in psychosis; Placebo for long‐term aggression in psychosis | None | ||
Oral | aripiprazole + magnesium valproate | Li 2009, Liu 2012, Xie 2011 | Magnesium valproate (+/‐aripiprazole) for psychosis‐induced aggression | None | |||
oral olanzapine | Chen 2009, Kinon 2008 | Aripiprazole (oral) for psychosis‐induced aggression or agitation (rapid tranquillisation); Olanzapine (oral) for psychosis‐induced aggression or agitation (rapid tranquillisation); | ? expansion of this review | ||||
+ clonazepam | oral clozapine | Bao 2007 | Aripiprazole plus benzodiazepines for psychosis‐induced aggression or agitation (rapid tranquillisation); Clozapine for psychosis‐induced aggression or agitation (rapid tranquillisation); | ? expansion of this review; Toal 2012 | |||
Non‐aripiprazole | |||||||
IM haloperidol + lorazepam + benztropine | oral quetiapine | Simpson 2010 | Benzodiazepines for psychosis‐induced aggression or agitation (rapid tranquillisation); Haloperidol for psychosis‐induced aggression or agitation (rapid tranquillisation); Quetiapine for psychosis‐induced aggression or agitation (rapid tranquillisation) | Gillies 2015;Ostinelli 2017;Wilkie 2012 |
* One sub‐study with people with aggression/agitation.